LAS VEGAS, Nov. 23, 2017 -- Global Wound Closure are hard-to-heal wounds that proceed through the repair process without exhibiting a sustained and functional result. Complications of chronic wounds include different infections such as infective venous eczema, cellulitis, gangrene, lower-extremity amputations, and hemorrhage. Chronic wounds significantly impact the health and the quality of life of the patients and their families due to the low base rate of complete healing. They can lead to pain, loss of mobility and function, distress and anxiety, depression, social isolation and embarrassment, prolonged hospital stays leading to financial burden and even death. According to California Podiatric Medical Association (CPMA), 15% of people diagnosed with diabetes tend to develop a foot ulcer and 14 to 24% patients affected by foot ulcers will require amputation during their lifetime. Pressure ulcers and diabetic foot ulcers are long-lasting wounds instigated by elevated pressure and reduced angiogenic response i.e., less formation of new blood cells. Diabetic foot ulcers are categorized by redness, unusual swelling and odor from feet that are a few early symptoms.
A few of the key factors propelling the growth of wound closure market are the increase in demand for less invasive procedures, predominance of chronic diseases across the world, and enhanced technology in wound care products. As per NCBI, pressure ulcers happen in 30 to 85% of patients suffering from spinal cord injuries, within the first month of injury. Development of cost effective products directed towards particular wounds will lead this market further. Therefore, cost efficiency and enhanced technology coupled with odor and pain control are a few prime factors which will rule the evolution of wound closure market in the coming years.
Get Free Sample of this Report: http://www.crystalmarketresearch.com/report/wound-closure-market
Moreover, increasing aging population vulnerable to chronic diseases such as diabetes leading to the heightened risk of chronic wounds will further contribute to the market growth. The global share of older people increased from 9.2% in 1990 to 11.7% in 2013 and will reach 21.1% by 2050 (Source: United Nations Department of Economic and Social Affairs). Further, it states that the number of older people is projected to reach 2 billion in 2050 from 841 million people in 2013. However, high cost of wound closure products and technical assistance for using these products will hamper the market growth.
Increased focus of key players on the development of innovative wound closure products to meet the unmet medical needs will further propel the market growth. For instance, in March 2017, Izun Pharmaceuticals Corporation obtained FDA approval for Curasite Wound Care Hydrogel for the treatment of leg ulcers and diabetic foot ulcers. Major players operating in this market are Smith & Nephew PLC, B. Braun Melsungen AG, 3M Company, Baxter International Inc., DeRoyalIndustries, Inc., Johnson & Johnson Services, Inc., Medtronic plc, CryoLife, Inc., Derma Sciences Inc. (acquired by Integra LifeSciences Holdings Corporation) and BSN medical GmbH (acquired by SVENSKA CELLULOSA AKTIEBOLAGET SCA (publ)).
Get Customize Copy: http://www.crystalmarketresearch.com/customization/HC06136
Key Findings of the Research Study:
- Increase in cases of road accidents and traumatic injuries are expected to largely contribute to the growth of wound closure market in coming years.
- With development of advanced wound closure products that effectively reduce the time to heal the wounds, the adoption of wound closure products is set to increase considerably during the forecast period.
- North America dominated the global wound closure market in 2016 due to increasing incidence of lifestyle disorders such as diabetes and growing geriatric population in the region.
- Asia-Pacific wound closure market is projected to witness significant growth during the forecast period owing to high prevalence of unmet medical needs in the region, increasing disposable income and efforts to improve healthcare infrastructure in developing countries such as China and India.
About Crystal Market Research
Crystal Market Research is a U.S. based market research and business intelligence company. Crystal offers one stop solution for market research, business intelligence, and consulting services to help clients make more informed decisions. It provides both syndicated as well as customized research studies for its customers spread across the globe. The company offers market intelligence reports across a broad range of industries including healthcare, chemicals & materials, technology, automotive, and energy.
Contact:
304 South Jones Blvd, Suite 1896,
Las Vegas NV 89107,
United States
Toll Free: + 1-888-213-4282
Email: [email protected]
Website: http://www.crystalmarketresearch.com


Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate
Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026 



